Revisiting the role of radiotherapy in Hodgkin lymphoma to augment systemic immunity.
Affiliation
Division of Cancer Sciences , School of Medical Sciences, University of Manchester, Christie Hospital, Manchester Academic Health Sciences Centre , Manchester , UKIssue Date
2018-06-22
Metadata
Show full item recordCitation
Revisiting the role of radiotherapy in Hodgkin lymphoma to augment systemic immunity. 2018: 1-2 Leuk LymphomaJournal
Leukemia & LymphomaDOI
10.1080/10428194.2018.1464160PubMed ID
29932777Type
ArticleLanguage
enISSN
1029-2403ae974a485f413a2113503eed53cd6c53
10.1080/10428194.2018.1464160
Scopus Count
Collections
Related articles
- Modern radiotherapeutic strategies in the management of lymphoma.
- Authors: Ballas L
- Issue date: 2015
- Recommendations for the use of radiotherapy in nodal lymphoma.
- Authors: Hoskin PJ, Díez P, Williams M, Lucraft H, Bayne M, Participants of the Lymphoma Radiotherapy Group
- Issue date: 2013 Jan
- Immune checkpoint inhibitors in Hodgkin and non-Hodgkin lymphoma: how they work and when to use them.
- Authors: Savage KJ, Steidl C
- Issue date: 2016 Nov
- Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
- Authors: Specht L
- Issue date: 2016 Jan
- [Radiotherapy of lymphomas].
- Authors: Barillot I, Mahé MA, Antoni D, Hennequin C
- Issue date: 2016 Sep